Protara Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update
Provided By GlobeNewswire
Last update: May 8, 2025
NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced financial results for the first quarter ended March 31, 2025, and provided a business update.
Read more at globenewswire.com
